Is 22-Oxovincaleukoblastine Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 22-Oxovincaleukoblastine? Is 22-Oxovincaleukoblastine safe for nursing mother and child? Does 22-Oxovincaleukoblastine extracts into breast milk? Does 22-Oxovincaleukoblastine has any long term or short term side effects on infants? Can 22-Oxovincaleukoblastine influence milk supply or can 22-Oxovincaleukoblastine decrease milk supply in lactating mothers?
22-Oxovincaleukoblastine lactation summary
- DrLact safety Score for 22-Oxovincaleukoblastine is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of 22-Oxovincaleukoblastine may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that 22-Oxovincaleukoblastine may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using 22-Oxovincaleukoblastine .
- Usage of 22-Oxovincaleukoblastine is in contradiction to breastfeeding hence if it is must to use 22-Oxovincaleukoblastine and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 22-Oxovincaleukoblastine usage in lactation
Drug is cleared from the body in 5 elimination half-lives. Return to breastfeeding is likely safe after 35 days of pumping-discarding of the milk.
Answer by DrLact: About 22-Oxovincaleukoblastine usage in lactation
Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy.[1] It is probably impractical to resume breastfeeding after 22-Oxovincaleukoblastine therapy because of the drug's long half-life. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[2]
22-Oxovincaleukoblastine Side Effects in Breastfeeding
In a 4-month-old, neutropenia was probably caused by cyclophosphamide in a mother 9 days after the last of 6 weekly doses of 800 mg cyclophosphamide intravenously, 2 mg 22-Oxovincaleukoblastine intravenously and daily doses of 30 mg of prednisolone orally. Neutropenia persisted at least 12 days and was accompanied by a brief episode of diarrhea.[3] The contribution of 22-Oxovincaleukoblastine to the neutropenia cannot be determined.
Alternate Drugs
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Cisplatin(Unsafe)
Bevacizumab(Low Risk)
Vinorelbine(Dangerous)
Busulfan(Dangerous)
Pazopanib(Unsafe)
Dacarbazine(Dangerous)
Trastuzumab(Unsafe)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Cladribine(Dangerous)
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Letrozole(Dangerous)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Vincristine(Dangerous)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Ipilimumab(Unsafe)
Mitoxantrone(Dangerous)
Dactinomycin(Dangerous)
Cetuximab(Unsafe)
Mercaptopurine(Safe)
Carboplatin(Dangerous)
Hydroxyurea(Low Risk)
Paclitaxel(Dangerous)
Etoposide(Dangerous)
Fluorouracil(Dangerous)
Nivolumab(Unsafe)
Doxorubicin(Dangerous)
Gemcitabine(Dangerous)
Alemtuzumab(Low Risk)
Vinblastine(Dangerous)
Cyclophosphamide(Dangerous)
Rituximab(Low Risk)